Copyright ©The Author(s) 2022.
World J Gastroenterol. Jul 21, 2022; 28(27): 3314-3333
Published online Jul 21, 2022. doi: 10.3748/wjg.v28.i27.3314
Figure 1
Figure 1 Progression of nonalcoholic fatty liver to cirrhosis and/or liver cancer and suggested dietary intervention in nonalcoholic fatty liver disease patients according to risk factors. DASH: Dietary Approach to Stop Hypertension; MUFA: Monounsaturated fatty acid; NAFL: Nonalcoholic fatty liver; NAFLD: Nonalcoholic fatty liver disease; NASH: Nonalcoholic steatohepatitis; PUFA: Polyunsaturated fatty acid; SFA: Saturated fatty acid. Blue fonts indicate evidence-based proven effect of the dietary component. Created in